Fundraising FoxVitruviae
Nutley, US · 1 known investors
Find your way into Vitruviae
Sign up to see every warm intro you have to Vitruviae
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vitruviae team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance. Its dual sugar-lipid targeting platform is engineered into formats such as T-cell engagers, CAR immune cells, and radioactive delivery platforms, with a lead program (VTRU200) for acute myeloid leukemia.
Founders & leadership
SS
Sonia SequeiraChief Executive Officer (CEO), founderShe previously served as VP of Translational Science and Early Clinical Development at Y-mAbs Therapeutics and spent a decade leading product development at Memorial Sloan Kettering Cancer Center. She also holds the role of Chief Translational and Regulatory Officer at pHLIP Inc.
MA
Mahiuddin AhmedPresident and Chief Scientific Officer (CSO)He was previously SVP and Chief Scientific Officer at Y-mAbs Therapeutics, and before that spent nearly a decade at Memorial Sloan Kettering Cancer Center, advancing from research fellow to senior research scientist and assistant member.
Investors · 1
Frequently asked questions
- What does Vitruviae do?
- VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance. Its dual sugar-lipid targeting platform is engineered into formats such as T-cell engagers, CAR immune cells, and radioactive delivery platforms, with a lead program (VTRU200) for acute myeloid leukemia.
- Who founded Vitruviae?
- Vitruviae was founded by Sonia Sequeira.
- Who are Vitruviae's investors?
- Vitruviae's investors include Angel Physicians Fund.
- Where is Vitruviae headquartered?
- Vitruviae is headquartered in Nutley, US.